Pure Global
NCT04900844

Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting

A Multicenter, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the CGuard™ Carotid Stent System When Used to Treat Symptomatic and Asymptomatic Carotid Artery Stenosis in Patients Undergoing Carotid Artery Stenting
InspireMD·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carotid Artery Stenosis
Drug/Device/Intervention
CGuard Carotid Stent implantation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
InspireMD
Location
New Orleans,Detroit,Cleveland,Harrisburg,Greenville,Sioux Falls,Kingsport,Knoxville,Austin, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2021
End date
Oct 01, 2025
Enrollment
315 participants
Primary outcome

Composite of DSMI through 30 days or ipsilateral stroke 31 - 365 days post-index procedure

Summary

The objective of this pivotal study is to evaluate the safety and efficacy of the CGuard™
 Carotid Stent System in the treatment of carotid artery stenosis in symptomatic and
 asymptomatic patients undergoing carotid artery stenting (CAS) to a performance goal
 developed from published CAS literature.

ICD-10 classifications
Occlusion and stenosis of carotid arteryCarotid artery syndrome (hemispheric)Injury of carotid arteryAneurysm and dissection of carotid arteryOcclusion and stenosis of vertebral artery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04900844
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04900844 through Pure Global AI's free database. This phase not specified trial is sponsored by InspireMD and is currently Recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 315 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.